Clinical Trial Update: The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer

View source ↗

Summary

This clinical trial assesses the utility and cost-effectiveness of 18F-FDG PET imaging for staging potentially operable non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Non Small Cell Lung Cancer | Status: UNKNOWN